EcoDrugPlus

Checkpoint Kinase 1

Ensembl ID : ENSLCAG00010009544
Gene Symbol: LOC108893136
4 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSLCAG00010024040
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Chemokine (C-C Motif) Receptor 9a

Ensembl ID : ENSLCAG00010006229
Gene Symbol: CCR9A
4 Cross references
188 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSLCAG00010009660
Gene Symbol: CCKBR
2 Cross references
190 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSLCAG00010027223
Gene Symbol: CCKBR
2 Cross references
190 Possible Orthologues:

Cholecystokinin B Receptor A

Ensembl ID : ENSLCAG00010014896
Gene Symbol: LOC108900614
4 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSLCAG00010010231
Gene Symbol: LOC108898059
4 Cross references
258 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSLCAG00010018974
Gene Symbol: LOC108902327
4 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSLCAG00010015438
Gene Symbol: CHRM2
4 Cross references
185 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSLCAG00010022551
Gene Symbol: CHRM3
1 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSLCAG00010017339
Gene Symbol: CHRM3
4 Cross references
187 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSLCAG00010020101
Gene Symbol: CHRM4
1 Cross references
184 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).